Palomino Laboratories (PALX) Cash from Financing Activities (2023 - 2025)

Palomino Laboratories has disclosed Cash from Financing Activities across 3 years of filings, most recently posting $8.1 million for Q3 2025.

• Cash from Financing Activities for Q3 2025 came in at $8.1 million, up 40476.29% year-over-year; the trailing twelve-month figure through Sep 2025 was $8.3 million (changed N/A YoY), and the FY2024 annual result was $195437.0, up 146.58% from the prior year.
• Cash from Financing Activities came in at $8.1 million for Q3 2025 at Palomino Laboratories, up from $19980.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $8.1 million in Q3 2025 to a low of $20.0 in Q1 2025.
• The 3-year median for Cash from Financing Activities is $38404.5 (2023), against an average of $1.4 million.
• Across the five-year window, Cash from Financing Activities surged 155.0% in 2024 and soared 40476.29% in 2025, its largest moves.
• Palomino Laboratories' Cash from Financing Activities stood at $56766.0 in 2023, then soared by 155.0% to $144753.0 in 2024, then surged by 5518.33% to $8.1 million in 2025.
• The last three Cash from Financing Activities figures came in at $8.1 million (Q3 2025), $19980.0 (Q2 2025), and $20.0 (Q1 2025), per Business Quant data.